LIGAND PHARMACEUTICALS INCORPORATED Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities of $0 as of 2022-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Notes › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities · last filed 2025-02-28
- 2022-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities $0.00.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2025-02-28 |